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Significance of the Study 
This novel study evaluates whether the magnitude of association between obesity and 





Objective: To examine the secular trends in the association between obesity and hypertension 
among American adults between 1999 and 2014. Methods: Data from the 1999-2014 National 
Health and Nutrition Examination Survey (eight survey cycles) were used. Obesity was 
determined from measured body mass index, with hypertension assessed from measured blood 
pressure and self-reported medication use. Meta-regression was used to examine the linear, 
quadratic, and cubic trends of the relationship between the observed odds ratio effect sizes 
(obesity and hypertension) and the NHANES cycles (year) using a random-effects model. 
Results: Across the years of 1999 to 2014, there was a significant, positive linear trend (p = 
0.006) in the association between overweight/obesity and hypertension. Conclusion: Our 
findings suggest that the association between overweight/obesity and hypertension is becoming 
stronger over time. Continued surveillance of temporal changes associated with obesity and 
hypertension is necessary to monitor how such changes may underlie changes in the risk for 
chronic disease. 
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Obesity is becoming an "epidemic" that plagues many parts of the industrialized world, 
contributing to a global health and economic burden (Hall, Crook, Jones, Wofford, & Dubbert, 
2002; Mark, Correia, Morgan, Shaffer, & Haynes, 1999). Recent estimates suggest that obesity 
affects 36.5% of all adults in the United States (Ogden, Carroll, Fryar, & Flegal, 2015). Excess 
weight is associated with various negative effects on health outcomes such as cardiovascular 
disease (Kenchaiah et al., 2002; Lavie, Milani, & Ventura, 2009), hypertension (Krauss, 
Winston, Fletcher, & Grundy, 1998), diabetes (Gregg, Cheng, Narayan, Thompson, & 
Williamson, 2007; Leibson et al., 2001), cancer (Calle, Rodriguez, Walker-Thurmond, & Thun, 
2003; Renehan, Tyson, Egger, Heller, & Zwahlen, 2008), and early mortality (Calle et al., 2003; 
Calle, Thun, Petrelli, Rodriguez, & Heath Jr, 1999).  
 
Between 2015 and 2016, the overall prevalence of hypertension was 29% and was higher among 
non-Hispanic black (40.3%) than among non-Hispanic white (27.8%), non-Hispanic Asian 
(25.0%), or Hispanic (27.8%) adults (Fryar, Ostchega, Hales, Zhang, & Kruszon-Moran, 2017). 
Hypertension is a well-established risk factor for stroke (Kannel et al., 1981), kidney disease 
(Jafar et al., 2003), and mortality (Garland, Barrett-Connor, Suarez, & Criqui, 1983). A diagnosis 
of hypertension is warranted for individuals with a systolic blood pressure (BP) greater than 130 
mmHg, a diastolic BP greater than 80 mmHg, or taking an antihypertensive medication (Muntner 




Moreover, overweight and obesity are associated with hypertension (Chiang, Perlman, & 
Epstein, 1969). According to previous research, obese and hypertensive patients report common 
risk factor symptomology, such as insulin resistance and/or type 2 diabetes (DeFronzo & 
Ferrannini, 1991), hyperinsulinemia (Masuo, Mikami, Ogihara, & Tuck, 2000), systemic 
hemodynamic (Hall, Brands, Dixon, & Smith, 1993), chronic kidney disease (Hall, 2003), and 
obstructive sleep apnea. (Phillips et al., 1999). Therefore, the synchronous deleterious effects of 
obesity and hypertension, in combination, may effectively contribute to increasing health care 
expenditures (Condliffe, Link, Parasuraman, & Pollack, 2013) and early mortality 
(Kurukulasuriya, Stas, Lastra, Manrique, & Sowers, 2011). 
 
A comprehensive understanding of secular trends in the association between obesity and 
hypertension is necessary as public health educators, clinicians and professionals attempt to 
demarcate time-sensitive changes in the distribution of health-influencing factors over time. 
Tracking potential temporal trends are useful for healthy policy reform, and national and local 
resource allocation to epidemiological research and disease prevention. Additionally, evaluating 
secular trends in the association between weight status and hypertension will provide useful 
information as to the acceptability and utility of pooling data from multiple time periods (e.g. 
different survey years) when examining the association between weight status and hypertension, 
or investigating factors that influence this relationship. Therefore, the main purpose of this study 
was to evaluate potential secular trends in the relationship between weight status and 





Study Design  
Data were extracted from eight cycles of the 1999-2014 National Health and Nutrition 
Examination Survey (NHANES). Data was released in two-year cycles (e.g., 1999-2000, 2001-
2002). The NHANES is an ongoing survey conducted by the Centers for Disease Control and 
Prevention that uses a representative sample of non-institutionalized United States civilians 
selected by a complex, multistage, stratified, clustered probability design. The multistage design 
includes the following four stages: 1) identification of counties; 2) identification of segments 
(city blocks); 3) random selection of households within the selected segments; and 4) random 
selection of individuals within the selected households. Procedures were approved by the review 
board of the National Center for Health Statistics. All participants provided consent to participate 
in the study prior to data collection. More details about NHANES methodology and data 
collection can be found on the NHANES website (http://www.cdc.gov/nchs/nhanes.htm).  
 
Measurement of Weight and Height Status 
Participants’ weight was measured using a digital weight scale and expressed in kilograms. After 
the examiner briefly introduced the exam to the participants, the recorder instructed the examinee 
to look straight at the center of the scale platform towards the recorder. Once the participant was 
correctly positioned and the reading of the digital measuring device stabilized, the recorder 
clicked the screen's weighing button to capture the result in the Integrated Survey Information 
System (ISIS). Participants’ height was measured using a digital stadiometer. The participant 
stood up straight against the backboard with the body weight evenly distributed and both feet flat 
on the platform. Participants were instructed to stand with their heels together and toes apart. 
While the participants were correctly positioned and holding the breath, the measurement on the 
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ISIS screen was taken. Further information on NHANES body measures collection is available 
on the NHANES website (http://www.cdc.gov/nchs/nhanes.htm). Body mass index (BMI) was 
calculated as the ratio between weight in kilograms and height in meters squared (kg/m2). 
Overweight and obese, respectively, were defined as having a BMI of 25-30 kg/m2 and ≥30 
kg/m2. 
 
Measurement of Hypertension 
Participants were classified as hypertensive, if they were currently taking BP medication or if the 
average of four measurements of their BP was ≥130/80 mmHg (Muntner et al., 2018). After five 
minutes of resting quietly in a sitting position and assessing the maximum inflation level, the BP 
measurements were taken. The BP technicians of NHANES obtained certification in BP 
measurement through a training program provided by the Shared Care Research and Education 
Consulting (Ostchega et al., 2003). The program included a didactic section, audio-video practice 
watching and listening to systolic and diastolic BP sounds, and measuring BP of volunteers 
concurrently with a certified, gold standard BP instructor.  
 
Statistical Analysis 
Using Stata (v. 12), multiple logistic regression was used to evaluate the association between 
weight status and hypertension (outcome variable) for each of the eight evaluated NHANES 
cycles (1999-2014). Models were computed for three separate weight status metrics: (1) BMI as 
a continuous variable; (2) obese vs. not obese; and (3) overweight/obese vs. not 




Comprehensive Meta-Analysis (CMA) software was used to evaluate the trend in the effect size 
between weight status and hypertension across the eight NHANES cycles. Specifically, we used 
a meta-regression to examine the linear, quadratic, and cubic trends of the relationship between 
the observed odds ratio effect sizes and the NHANES cycles (year) using a random-effects 
model (under the assumption of between-study heterogeneity). The degree of heterogeneity of 
the effect sizes was evaluated with the Cochran’s Q-statistic, while the proportion of variation 
attributable to between-study heterogeneity was evaluated with I2 index.  
 
Results 
Across the 1999-2014 NHANES cycles, only adults 20+ years of age were included in the 
analyses. Among those with complete data on the study variables (age, gender, race-ethnicity, 
BMI, and BP), the total sample size was 38,993. Table 1 displays the study variable 
characteristics across each cycle. Participants, on average, were similar for each of the evaluated 
variables across the cycles, with the exception of age and BMI, which slightly increased over 
time. 
 
Figure 1 displays the results for the association between BMI (continuous) and hypertension. 
Across the years of 1999 to 2014, the pooled association between BMI and hypertension was 
statistically significant (OR = 1.09, 95% CI = 1.08-1.09, p < 0.001). That is, for every 1 kg/m2 
increase in BMI, adults had a 9% increased odds of being hypertensive. Regarding the trend in 
the association between BMI and hypertension across the eight NHANES cycles, there were no 
statistically significant linear trend (unstandardized regression coefficient [b] = 0.001, p = 
0.081), quadratic trend (p = 0.852), or cubic trend (p = 0.123); however, at the sample level, 
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there was a slight increase in the odds ratio effect sizes across the NHANES cycles (Figure 2). 
There was moderate evidence of heterogeneity (Q(7) = 13.59, p = 0.058, I2 = 48.50%). 
 
Figure 3 displays the results for the association between obesity (vs. not obese) and hypertension. 
Across the years of 1999 to 2014, the pooled association between obesity and hypertension was 
statistically significant (OR = 2.51, 95% CI = 2.27-2.76, p < 0.001). That is, on average across 
the cycles, obese individuals had 2.51 times higher odds of being hypertensive when compared 
to non-obese adults. Regarding the trend in the association between obesity and hypertension 
across the eight NHANES cycles, there were no statistically significant linear trend (b = 0.02, p 
= 0.091), quadratic trend (p = 0.980), or cubic trend (p = 0.261); however, at the sample level, 
there was a slight increase in the odds ratio effect sizes across the NHANES cycles (Figure 4). 
There was moderate heterogeneity in the effect sizes (Q(7) = 12.91, p = 0.074, I2 = 45.79%). 
 
Figure 5 displays the results for the association between overweight/obesity (vs. not 
overweight/obese) and hypertension. Across the years 1999 to 2014, the pooled association 
between overweight/obesity and hypertension was statistically significant (OR = 2.23, 95% CI = 
2.03-2.44, p < 0.001). That is, on average across the cycles, overweight/obese individuals had a 
2.23 higher odds of being hypertensive when compared to non-overweight/obese adults. 
Regarding the trend (Figure 6) in the association between overweight/obesity and hypertension 
across the eight NHANES cycles, there was statistically significant linear trend (b = 0.02, p = 
0.006) indicating a slight increase in the odds ratios across the NHANES cycles. Quadratic trend 
(p = 0.972) and cubic trend (p = 0.046) were not statistically significant. There was moderate 




Given the observed linear trend between the association of overweight/obesity and hypertension, 
we evaluated whether there were parallel secular trends in the prevalence of overweight/obesity 
during this same period. Across the 8 respective NHANES cycles, the prevalence of 
overweight/obesity was 64%, 65%, 66%, 66%, 68%, 69%, 68%, and 70% (ptrend < 0.001). 
  
Discussion 
Previous studies have demonstrated an association between increased weight status and various 
deleterious health outcomes (Kenchaiah et al., 2002; Lavie et al., 2009), including hypertension 
(Krauss et al., 1998). Other work has also evaluated secular trends in weight status alone (Hales, 
Fryar, Carroll, Freedman, & Ogden, 2018), as well as trends in hypertension status (Rao, 2012). 
To date, however, no study has evaluated the secular trends of the relationship between weight 
status and hypertension, which was the purpose of this project. By pooling results from eight 
NHANES cycles, including a total of 38,993 participants, we found that people with higher BMI, 
and people who were categorized as overweight or obese, were more likely to be hypertensive. 
Further, our findings demonstrate that, between 1999 and 2014, the association between 
overweight/obesity (vs. not overweight/obese) and hypertension among the broader American 
adult population became stronger.  
 
When evaluated across the years 1999 to 2008, the prevalence of obesity was 33.8% among 
adults in 2007 to 2008, with similar rates observed between 1999 and 2000 (Flegal, Carroll, 
Ogden, & Curtin, 2010). According to another study, the prevalence of obesity was 35.5% in 
adult males and 35.8% in adult females, with no significant change in obesity prevalence over 
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the 12-year period from 1999 through 2010 (Flegal, Carroll, Kit, & Ogden, 2012). Additionally, 
secular trends in hypertension diagnoses among U.S adults have also been evaluated. When 
assessed across the years 1999 to 2010, the prevalence of hypertension was 30.5% among men 
and 28.5% among women. Similar to the aforementioned papers, there was no evidence of 
changes in the prevalence across the time-period investigated (Guo, He, Zhang, & Walton, 
2012). Relatedly, Yoon et al. (Yoon, Fryar, & Carroll, 2015) assessed hypertension prevalence 
from 2011 to 2014, reporting an average of 29% (30% for men and 28.1% for women) across the 
four-year assessment period. Taken together, there is little evidence of a secular trend in 
hypertension among American adults from 1999-2014 (Guo et al., 2012; Yoon et al., 2015). 
 
In the present study, we confirmed the results of other studies demonstrating an association 
between weight status and hypertension (Cheung et al., 2017; Krauss et al., 1998; Parker et al., 
2016; Someya et al., 2018). Adding novelty to the literature, our results suggest that the 
magnitude of this robust association is increasing over time. Given these findings, data-driven 
public health initiatives will be able to provide useful information to aid funding and resource 
allocation, as well as to substantiate proposals for local or national-level public health policy 
development, implementation and evaluation of intervention efforts to mitigate the ill-effects of 
increased weight and hypertension. 
 
In conclusion, we observed relatively strong associations between weight status and 
hypertension. We also observed evidence that the magnitude of association between 
overweight/obesity and hypertension has been increasing over time. This finding should be taken 
into account when combining [NHANES] weight status and hypertension data across multiple 
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years, particularly if the research objective is to evaluate the association between obesity and 
hypertension. Future studies should aim to identify reasons for the increasing magnitude of 
association between overweight/obesity and hypertension over time. Other work on this topic 
should evaluate whether there are secular trends in the relationship between determinants (e.g., 
dietary, environmental) that may influence the obesity-hypertension relationship.  
 





Table 1. Characteristics of the sample across the eight NHANES cycles. 
 NHANES cycle 
 1999-2000 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012 2013-2014 
N 4234 4520 4337 4466 5358 5731 5008 5339 
Age, mean yrs 45.8 (0.4) 45.7 (0.4) 46.0 (0.4) 46.4 (0.7) 46.7 (0.4) 47.0 (0.4) 47.3 (0.8) 47.3 (0.4) 
Gender, % female 51.7 51.8 51.2 51.7 51.9 51.6 51.4 51.7 
Race-Ethnicity, % white 69.8 73.2 72.6 72.4 69.6 68.4 66.8 65.9 
BMI, mean kg/m2 28.0 (0.2) 28.0 (0.2) 28.1 (0.1) 28.4 (0.2) 28.5 (0.1) 28.7 (0.1) 28.7 (0.2) 29.1 (0.2) 
















DBP, mean mmHg 72.3 (0.4) 72.1 (0.4) 70.9 (0.3) 70.2 (0.3) 70.7 (0.3) 69.5 (0.6) 71.4 (0.5) 69.8 (0.3) 
% Hypertensive 39.5 39.2 40.8 40.1 39.3 39.2 41.4 40.6 
BMI, body mass index 
DBP, diastolic blood pressure 
SBP, systolic blood pressure 




































Figure 6. Trend in the association between overweight/obesity (vs. not) and hypertension 
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